Daily Stock Analysis, CGEN, Compugen Ltd, priceseries

Compugen Ltd. Daily Stock Analysis
Stock Information
Open
4.20
Close
4.35
High
4.39
Low
4.20
Previous Close
4.20
Daily Price Gain
0.15
YTD High
5.40
YTD High Date
Jan 6, 2017
YTD Low
4.20
YTD Low Date
Mar 24, 2017
YTD Price Change
-0.75
YTD Gain
-14.71%
52 Week High
7.57
52 Week High Date
Sep 2, 2016
52 Week Low
4.20
52 Week Low Date
Mar 24, 2017
52 Week Price Change
-1.22
52 Week Gain
-21.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
May 27. 2015
6.55
Jun 9. 2015
7.34
9 Trading Days
12.00%
Link
LONG
Oct 13. 2015
5.59
Oct 29. 2015
6.17
12 Trading Days
10.36%
Link
LONG
Nov 13. 2015
6.72
Dec 3. 2015
7.43
13 Trading Days
10.59%
Link
LONG
Apr 6. 2016
6.13
Apr 28. 2016
6.76
16 Trading Days
10.25%
Link
LONG
Nov 7. 2016
6.05
Nov 18. 2016
6.44
9 Trading Days
6.40%
Link
Company Information
Stock Symbol
CGEN
Exchange
NasdaqGM
Company URL
http://www.cgen.com
Company Phone
011-972-3-765-8585
CEO
Anat Cohen-Dayag
Headquarters
-
Business Address
72 PINCHAS ROSEN ST, TEL AVIV, ISRAEL 69512
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001119774
About

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe.

Description

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company primarily focuses on immune checkpoint target candidates to serve as drug targets for cancer immunotherapies addressing various cancer types and patient populations. Its antibody drug conjugate target candidates include CGEN-15001T, CGEN-15022, CGEN-15029, CGEN-15049, CGEN-15027, CGEN-15052, and CGEN-15092 for immuno-oncology; and therapeutic proteins comprise CGEN-15001 for autoimmune diseases. The company was incorporated in 1993 and is headquartered in Holon, Israel.